Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: Implications for HAND

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 3, 2013, Pages 621-642

  Gaskill, Peter J ^a   Calderon, Tina M ^a   Coley, Jacqueline S ^a   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine; Drug abuse; HIV associated neurological disorders; Macrophage; Monocyte; Neuroinflammation; T cell

Indexed keywords

COCAINE; CYTOKINE; DIAMORPHINE; DOPAMINE; HYDROGEN PEROXIDE; METHAMPHETAMINE; NITRIC OXIDE;

CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; DENDRITIC CELL; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG DEPENDENCE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MONOCYTE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

AIDS DEMENTIA COMPLEX; ANIMALS; CENTRAL NERVOUS SYSTEM; DOPAMINE; DOPAMINE AGENTS; HIV INFECTIONS; HUMANS; MACROPHAGES; MONOCYTES; STREET DRUGS; T-LYMPHOCYTES;

EID: 84878800186     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9443-y     Document Type: Review

References (265)

1. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593-623. doi: 10.1146/annurev.immunol.17.1.593
2. Ali RA, Qureshi MA, McCorkle FM (1994) Profile of chicken macrophage functions after exposure to catecholamines in vitro. Immunopharmacol Immunotoxicol 16(4):611-625. doi: 10.3109/08923979409019742
3. Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27(1):86-92. doi: 10.1055/s-2006-956759
4. Ancuta P, Kunstman KJ, Autissier P, Zaman T, Stone D, Wolinsky SM, Gabuzda D (2006) CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344(2):267-276. doi: 10.1016/j.virol.2005.10.027
5. Anlauf M, Schafer MK, Schwark T, von Wurmb-Schwark N, Brand V, Sipos B, Horny HP, Parwaresch R, Hartschuh W, Eiden LE, Kloppel G, Weihe E (2006) Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis. J Histochem Cytochem Off J Histochem Soc 54(2):201-213. doi: 10.1369/jhc.5A6739.2005
6. Anthony IC, Crawford DH, Bell JE (2003) B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain 126(Pt 5):1058-1067
7. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 64(6):529-536
8. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789-1799. doi: 10.1212/01.WNL.0000287431.88658.8b
9. Asselman V, Thienemann F, Pepper DJ, Boulle A, Wilkinson RJ, Meintjes G, Marais S (2010) Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS 24(18):2871-2876. doi: 10.1097/QAD. 0b013e328340fe76
10. Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ (1998) A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 287:187-197
11. Bailer RT, Lee B, Montaner LJ (2000) IL-13 and TNF-alpha inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur J Immunol 30(5):1340-1349
12. Bailey SL, Schreiner B, McMahon EJ, Miller SD (2007) CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 8(2):172-180. doi: 10.1038/ni1430
13. Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD (2008) Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 180(10):6457-6461
14. Basso MR, Bornstein RA (2003) Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. J Clin Exp Neuropsychol 25(7):893-903. doi: 10.1076/jcen.25.7.893.16489
15. Basu B, Sarkar C, Chakroborty D, Ganguly S, Shome S, Dasgupta PS, Basu S (2010) D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in Jurkat T leukemic cells. J Biol Chem 285(35):27026-27032. doi: 10.1074/jbc.M110.144022
16. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63(1):182-217. doi: 10.1124/pr.110.002642
17. Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S (2012) TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation 9:23. doi: 10.1186/1742-2094-9-23
18. Bell JE, Busuttil A, Ironside JW, Rebus S, Donaldson YK, Simmonds P, Peutherer JF (1993) Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 168(4):818-824
19. Berger JR, Arendt G (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14(3):214-221
20. Bergquist J, Tarkowski A, Ekman R, Ewing A (1994) Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A 91(26):12912-12916
21. Bergquist J, Ohlsson B, Tarkowski A (2000) Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann N Y Acad Sci 917:281-289
22. Besser MJ, Ganor Y, Levite M (2005) Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J Neuroimmunol 169(1-2):161-171. doi: 10.1016/j.jneuroim.2005.07.013
23. Bettelli E, Korn T, Oukka M, Kuchroo VK (2008) Induction and effector functions of T(H)17 cells. Nature 453(7198):1051-1057. doi: 10.1038/nature07036
24. Beyrer C, Wirtz AL, Baral S, Peryskina A, Sifakis F (2010) Epidemiologic links between drug use and HIV epidemics: an international perspective. J Acquir Immune Defic Syndr 55(Suppl 1):S10-S16. doi: 10.1097/QAI.0b013e3181f9c0c9
25. Bhavan KP, Kampalath VN, Overton ET (2008) The aging of the HIV epidemic. Curr HIV AIDS Rep 5(3):150-158
26. Bidart JM, Motte P, Assicot M, Bohuon C, Bellet D (1983) Catechol-O-methyltransferase activity and aminergic binding sites distribution in human peripheral blood lymphocyte subpopulations. Clin Immunol Immunopathol 26(1):1-9
27. Binford MC, Kahana SY, Altice FL (2012) A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV AIDS Rep 9(4):287-312. doi: 10.1007/s11904-012-0134-8
28. Boneberg EM, von Seydlitz E, Propster K, Watzl H, Rockstroh B, Illges H (2006) D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells. J Neuroimmunol 173(1-2):180-187. doi: 10.1016/j.jneuroim.2005.11.018
29. Brabers NA, Nottet HS (2006) Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Investig 36(7):447-458. doi: 10.1111/j.1365-2362.2006.01657.x
30. Brioni JD, Moreland RB, Cowart M, Hsieh GC, Stewart AO, Hedlund P, Donnelly-Roberts DL, Nakane M, Lynch JJ 3rd, Kolasa T, Polakowski JS, Osinski MA, Marsh K, Andersson KE, Sullivan JP (2004) Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc Natl Acad Sci U S A 101:6758-6763
31. Brown SW, Meyers RT, Brennan KM, Rumble JM, Narasimhachari N, Perozzi EF, Ryan JJ, Stewart JK, Fischer-Stenger K (2003) Catecholamines in a macrophage cell line. J Neuroimmunol 135(1-2):47-55
32. Buckner CM, Luers AJ, Calderon TM, Eugenin EA, Berman JW (2006) Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J NeuroImmune Pharm Off J Soc NeuroImmune Pharm 1(2):160-181. doi: 10.1007/s11481-006-9017-3
33. Buckner CM, Calderon TM, Willams DW, Belbin TJ, Berman JW (2011) Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cell Immunol 267(2):109-123. doi: 10.1016/j.cellimm.2010.12.004
34. Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, Sugimoto C, Alvarez X, Kuroda MJ, Williams KC (2010) Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 6(4):e1000842. doi: 10.1371/journal.ppat.1000842
35. Buscemi L, Ramonet D, Geiger JD (2007) Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis 26(3):661-670. doi: 10.1016/j.nbd.2007.03.004
36. Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, Atkinson JH, Clifford DB, Collier AC, Marra CM, Gelman B, McCutchan JA, Duarte NA, Simpson DM, McArthur J, Grant I (2011) Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr 58(2):154-162. doi: 10.1097/QAI.0b013e318229ba41
37. Capellino S, Cosentino M, Wolff C, Schmidt M, Grifka J, Straub RH (2010) Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis 69(10):1853-1860. doi: 10.1136/ard.2009.119701
38. Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28(3):653-661
39. Carvalho-Freitas MI, Rodrigues-Costa EC, Nasello AG, Palermo-Neto J, Felicio LF (2008) In vitro macrophage activity: biphasic effect of prolactin and indirect evidence of dopaminergic modulation. Neuroimmunomodulation 15(2):131-139. doi: 10.1159/000148196
40. Carvalho-Freitas MI, Anselmo-Franci JA, Maiorka PC, Palermo-Neto J, Felicio LF (2011) Prolactin differentially modulates the macrophage activity of lactating rats: possible role of reproductive experience. J Reprod Immunol 89(1):38-45. doi: 10.1016/j.jri.2010.12.008
41. Chang JY, Liu LZ (2000) Catecholamines inhibit microglial nitric oxide production. Brain Res Bull 52(6):525-530
42. Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS (2008) Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. NeuroImage 42(2):869-878. doi: 10.1016/j.neuroimage.2008.05.011
43. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ (2006) Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Investig 116(5):1317-1326. doi: 10.1172/JCI25308
44. Clay CC, Rodrigues DS, Ho YS, Fallert BA, Janatpour K, Reinhart TA, Esser U (2007) Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J Virol 81(21):12040-12048. doi: 10.1128/JVI.00133-07
45. Colton CA (2012) Immune heterogeneity in neuroinflammation: dendritic cells in the brain. J NeuroImmune Pharm Off J Soc NeuroImmune Pharm. doi: 10.1007/s11481-012-9414-8
46. Cosentino M, Bombelli R, Ferrari M, Marino F, Rasini E, Maestroni GJ, Conti A, Boveri M, Lecchini S, Frigo G (2000) HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci 68(3):283-295
47. Cosentino M, Fietta AM, Ferrari M, Rasini E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F, Lecchini S (2007) Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 109(2):632-642. doi: 10.1182/blood-2006-01-028423
48. Cosenza MA, Zhao ML, Si Q, Lee SC (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12(4):442-455
49. Cowart M, Latshaw SP, Bhatia P, Daanen JF, Rohde J, Nelson SL, Patel M, Kolasa T, Nakane M, Uchic ME, Miller LN, Terranova MA, Chang R, Donnelly-Roberts DL, Namovic MT, Hollingsworth PR, Martino BR, Lynch JJ 3rd, Sullivan JP, Hsieh GC, Moreland RB, Brioni JD, Stewart AO (2004) Discovery of 2-(4-pyridin-2- ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. J Med Chem 47:3853-3864
50. Cragg SJ, Rice ME (2004) DAncing past the DAT at a DA synapse. Trends Neurosci 27(5):270-277. doi: 10.1016/j.tins.2004.03.011
51. Crowe S, Zhu T, Muller WA (2003) The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol 74(5):635-641. doi: 10.1189/jlb.0503204
52. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924):744-748. doi: 10.1038/nature01355
53. Cysique LA, Maruff P, Brew BJ (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 10(6):350-357. doi: 10.1080/13550280490521078
54. Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73(5):342-348. doi: 10.1212/WNL.0b013e3181ab2b3b
55. Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller JG, Pedersen V, Gsell W, Heeney JL, Gerlach M, Gosztonyi G, Riederer P, ter Meulen V (2001) Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol 101(2):85-91
56. Czub S, Czub M, Koutsilieri E, Sopper S, Villinger F, Muller JG, Stahl-Hennig C, Riederer P, Ter Meulen V, Gosztonyi G (2004) Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol 107(3):216-226. doi: 10.1007/s00401-003-0801-3
57. D'Agostino PM, Gottfried-Blackmore A, Anandasabapathy N, Bulloch K (2012) Brain dendritic cells: biology and pathology. Acta Neuropathol. doi: 10.1007/s00401-012-1018-0
58. Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508(1):1-12. doi: 10.1016/j.abb.2010. 12.017
59. D'Aversa TG, Eugenin EA, Berman JW (2008) CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1). J Neurosci Res 86(3):630-639. doi: 10.1002/jnr.21525
60. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42(9):1736-1739
61. Delobel P, Sandres-Saune K, Cazabat M, L'Faqihi FE, Aquilina C, Obadia M, Pasquier C, Marchou B, Massip P, Izopet J (2005) Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS 19(16):1739-1750
62. Desai RI, Paronis CA, Martin J, Desai R, Bergman J (2010) Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. J Pharmacol Exp Ther 333(3):834-843. doi: 10.1124/jpet.110.165746
63. Dhillon NK, Williams R, Callen S, Zien C, Narayan O, Buch S (2008) Roles of MCP-1 in development of HIV-dementia. Front Biosci J Virtual Libr 13:3913-3918
64. Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7(1):69-76. doi: 10.1016/j.coph.2006. 11.003
65. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85(14):5274-5278
66. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178(10):6581-6589
67. Epstein LG, Gendelman HE (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33(5):429-436. doi: 10.1002/ana.410330502
68. Eugenin EA, Berman JW (2007) Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci Off J Soc Neurosci 27(47):12844-12850. doi: 10.1523/JNEUROSCI.4154-07.2007
69. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 85(5):1299-1311
70. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci Off J Soc Neurosci 26(4):1098-1106. doi: 10.1523/JNEUROSCI.3863-05.2006
71. Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A 104(9):3438-3443. doi: 10.1073/pnas.0611699104
72. Eugenin EA, King JE, Hazleton JE, Major EO, Bennett MV, Zukin RS, Berman JW (2011) Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity. Neurotox Res 19(1):138-148. doi: 10.1007/s12640-010-9150-x
73. Everall IP, Hansen LA, Masliah E (2005) The shifting patterns of HIV encephalitis neuropathology. Neurotox Res 8(1-2):51-61
74. Farber K, Pannasch U, Kettenmann H (2005) Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci 29(1):128-138. doi: 10.1016/j.mcn.2005.01.003
75. Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32(5):883-909. doi: 10.1016/j.neubiorev.2008.01.004
76. Fischer-Smith T, Rappaport J (2005) Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 7(27):1-26. doi: 10.1017/S1462399405010239
77. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J (2001) CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7(6):528-541. doi: 10.1080/135502801753248114
78. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR, Ward PA (2007) Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449(7163):721-725. doi: 10.1038/nature06185
79. Garris PA, Ciolkowski EL, Pastore P, Wightman RM (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci Off J Soc Neurosci 14(10):6084-6093
80. Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, Berman JW (2009) Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol 175(3):1148-1159. doi: 10.2353/ajpath.2009.081067
81. Gaskill PJ, Carvallo L, Eugenin EA, Berman JW (2012) Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation 9(1):203. doi: 10.1186/1742-2094-9- 203
82. Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH Jr, Soukup VM (2012) Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J NeuroImmune Pharm Off J Soc NeuroImmune Pharm 7(3):686-700. doi: 10.1007/s11481-012-9345-4
83. Ghosh MC, Mondal AC, Basu S, Banerjee S, Majumder J, Bhattacharya D, Dasgupta PS (2003) Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int Immunopharmacol 3(7):1019-1026. doi: 10.1016/S1567-5769(03)00100-0
84. Girault JA, Greengard P (2004) The neurobiology of dopamine signaling. Arch Neurol 61(5):641-644. doi: 10.1001/archneur.61.5.641
85. Glase SA, Akunne HC, Georgic LM, Heffner TG, MacKenzie RG, Manley PJ, Pugsley TA, Wise LD (1997) Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists. J Med Chem 40:1771-1772
86. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38(5):755-762. doi: 10.1002/ana.410380510
87. Gomez F, Ruiz P, Briceno F, Rivera C, Lopez R (1999) Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs. Clin Immunol 90(3):375-387. doi: 10.1006/clim.1998.4665
88. Gong N, Liu J, Reynolds AD, Gorantla S, Mosley RL, Gendelman HE (2011) Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis. J Neuroimmunol 230(1-2):33-41. doi: 10.1016/j.jneuroim.2010.08.014
89. Gonon FG, Buda MJ (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14(3):765-774
90. Gouwy M, Struyf S, Noppen S, Schutyser E, Springael JY, Parmentier M, Proost P, Van Damme J (2008) Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol Pharmacol 74(2):485-495. doi: 10.1124/mol.108.045146
91. Gray F, Lescs MC, Keohane C, Paraire F, Marc B, Durigon M, Gherardi R (1992) Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 51(2):177-185
92. Gruol DL, Nelson TE (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15(3):307-339. doi: 10.1007/BF02740665
93. Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten GP, Ayyavoo V (2012) Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells. J Neuroinflammation 9(1):138. doi: 10.1186/1742-2094-9-138
94. Guo W, Urizar E, Kralikova M, Mobarec JC, Shi L, Filizola M, Javitch JA (2008) Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 27(17):2293-2304. doi: 10.1038/emboj.2008.153
95. Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ (2012) Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS One 7(11):e40623. doi: 10.1371/journal.pone.0040623
96. Hasbi A, O'Dowd BF, George SR (2011) Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain 4:26. doi: 10.1186/1756-6606-4-26
97. Hasko G, Szabo C, Nemeth ZH, Deitch EA (2002) Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol 122(1-2):34-39
98. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087-2096. doi: 10.1212/WNL.0b013e318200d727
99. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3-16. doi: 10.1007/s13365-010-0006-1
100. Herbein G, Varin A (2010) The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7:33. doi: 10.1186/1742-4690-7-33
101. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28(2):254-260. doi: 10.1002/jnr.490280213
102. Hoeger S, Reisenbuechler A, Gottmann U, Doyon F, Braun C, Kaya Z, Seelen MA, van Son WJ, Waldherr R, Schnuelle P, Yard BA (2008) Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int Off J Eur Soc Organ Transplant 21(11):1072-1080. doi: 10.1111/j.1432-2277.2008.00725.x
103. Hohman M, Gregory K, Chibale K, Smith PJ, Ekins S, Bunin B (2009) Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. Drug Discov Today 14:261-270
104. Horn AS (1990) Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 34(5):387-400
105. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR (2010) Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J Off Publ Fed Am Soc Exp Biol 24(4):1023-1034. doi: 10.1096/fj.09-141978
106. Ilani T, Strous RD, Fuchs S (2004) Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J Off Publ Fed Am Soc Exp Biol 18(13):1600-1602. doi: 10.1096/fj.04-1652fje
107. Iversen SD, Iversen LL (2007) Dopamine: 50 years in perspective. Trends Neurosci 30(5):188-193. doi: 10.1016/j.tins.2007.03.002
108. Javitch JA (2004) The ants go marching two by two: oligomeric structure of G-protein-coupled receptors. Mol Pharmacol 66(5):1077-1082. doi: 10.1124/mol.104.006320
109. Jenny-Avital ER, Abadi M (2002) Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis Off Publ Infect Dis Soc Am 35(12):e128-e133. doi: 10.1086/344467
110. Johnson T, Nath A (2011) Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol 24(3):284-290. doi: 10.1097/WCO.0b013e328346be57
111. Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D (2012) Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr 60(3):234-243. doi: 10.1097/QAI.0b013e318256f3bc
112. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y (2007) HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 27(1):123-134. doi: 10.1038/sj.jcbfm.9600330
113. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173-1175. doi: 10.1038/nm1651
114. Kieburtz KD, Epstein LG, Gelbard HA, Greenamyre JT (1991) Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications. Arch Neurol 48(12):1281-1284
115. Kim WK, Sun Y, Do H, Autissier P, Halpern EF, Piatak M Jr, Lifson JD, Burdo TH, McGrath MS, Williams K (2010) Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol 87(4):557-567. doi: 10.1189/jlb.0209082
116. Kimmel HL, Ginsburg BC, Howell LL (2005) Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys. Synapse 56(3):129-134. doi: 10.1002/syn.20135
117. King JE, Eugenin EA, Hazleton JE, Morgello S, Berman JW (2010) Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis. Am J Pathol 176(6):2819-2830. doi: 10.2353/ajpath.2010.090642
118. Kipnis J, Cardon M, Avidan H, Lewitus GM, Mordechay S, Rolls A, Shani Y, Schwartz M (2004) Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. J Neurosci Off J Soc Neurosci 24(27):6133-6143. doi: 10.1523/JNEUROSCI.0600-04.2004
119. Knoblach SM, Faden AI (1998) Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 153(1):143-151. doi: 10.1006/exnr.1998.6877
120. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233(4768):1089-1093
121. Kokkinou I, Fragoulis EG, Vassilacopoulou D (2009) The U937 macrophage cell line expresses enzymatically active L-Dopa decarboxylase. J Neuroimmunol 216(1-2):51-58. doi: 10.1016/j.jneuroim.2009.09.001
122. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177(1):566-573
123. Koob GF (1992a) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13(5):177-184
124. Koob GF (1992b) Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 654:171-191
125. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242(4879):715-723
126. Kopin IJ (1994) Monoamine oxidase and catecholamine metabolism. J Neural Transm Suppl 41:57-67
127. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC (1997) Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 17(3):280-289. doi: 10.1097/00004647-199703000-00005
128. Kousik SM, Napier TC, Carvey PM (2012) The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol 3:121. doi: 10.3389/fphar.2012.00121
129. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002a) Involvement of dopamine in the progression of AIDS dementia complex. J Neural Transm 109(3):399-410. doi: 10.1007/s007020200032
130. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002b) Parkinsonism in HIV dementia. J Neural Transm 109(5-6):767-775. doi: 10.1007/s007020200063
131. Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64(1):133-145. doi: 10.1016/j.neuron.2009.09.042
132. Kulagowski JJ, Broughton HB, Curtis NR, Mawer IM, Ridgill MP, Baker R, Emms F, Freedman SB, Marwood R, Patel S, Patel S, Ragan CI, Leeson PD (1996) 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem 39:1941-1942
133. Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M (2011) Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol 17(1):26-40. doi: 10.1007/s13365-010-0003-4
134. Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ (1999) TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol 163(7):3653-3661
135. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E (2003) Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34(5):467-474
136. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233-240. doi: 10.1084/jem.20041257
137. Laskin DL, Sunil VR, Gardner CR, Laskin JD (2011) Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51:267-288. doi: 10.1146/annurev.pharmtox.010909.105812
138. Levite M (2008) Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 8(4):460-471. doi: 10.1016/j.coph.2008.05.001
139. Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L (2001) Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol 31(12):3504-3512. doi:10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F
140. Liang H, Wang X, Chen H, Song L, Ye L, Wang SH, Wang YJ, Zhou L, Ho WZ (2008) Methamphetamine enhances HIV infection of macrophages. Am J Pathol 172(6):1617-1624. doi: 10.2353/ajpath.2008.070971
141. Lin Y, Quartermain D, Dunn AJ, Weinshenker D, Stone EA (2008) Possible dopaminergic stimulation of locus coeruleus alpha1-adrenoceptors involved in behavioral activation. Synapse 62(7):516-523. doi: 10.1002/syn.20517
142. Liu J, Gong N, Huang X, Reynolds AD, Mosley RL, Gendelman HE (2009) Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol 182(6):3855-3865. doi: 10.4049/jimmunol.0803330
143. Lopez CA, Vazquez M, Hill MD, Colon Mdel C, Porrata-Doria T, Johnston IC, Lorenzo E (2010) Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART. Arch Virol 155(6):895-903. doi: 10.1007/s00705-010-0659-3
144. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350. doi: 10.1146/annurev.immunol.15.1.323
145. Madden LJ, Zandonatti MA, Flynn CT, Taffe MA, Marcondes MC, Schmitz JE, Reimann KA, Henriksen SJ, Fox HS (2004) CD8+ cell depletion amplifies the acute retroviral syndrome. J Neurovirol 10(Suppl 1):58-66
146. Makrigeorgi-Butera M, Hagel C, Laas R, Puschel K, Stavrou D (1996) Comparative brain pathology of HIV-seronegative and HIV-infected drug addicts. Clin Neuropathol 15(6):324-329
147. Marcondes MC, Burudi EM, Huitron-Resendiz S, Sanchez-Alavez M, Watry D, Zandonatti M, Henriksen SJ, Fox HS (2001) Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol 167(9):5429-5438
148. Marcondes MC, Sopper S, Sauermann U, Burdo TH, Watry D, Zandonatti M, Fox HS (2008) CD4 deficits and disease course acceleration can be driven by a collapse of the CD8 response in rhesus macaques infected with simian immunodeficiency virus. AIDS 22(12):1441-1452. doi: 10.1097/QAD.0b013e3283052fb5
149. Martin-Blondel G, Alvarez M, Delobel P, Uro-Coste E, Cuzin L, Cuvinciuc V, Fillaux J, Massip P, Marchou B (2011) Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 82(6):691-693. doi: 10.1136/jnnp.2009.199919
150. Martin-Blondel G, Mars LT, Liblau RS (2012) Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients. Curr Opin Infect Dis 25(3):312-320. doi: 10.1097/QCO.0b013e328352b664
151. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP (2008) Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372(9651):1733-1745. doi: 10.1016/S0140-6736(08)61311-2
152. Matulenko MA, Hakeem AA, Kolasa T, Nakane M, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts DL, Namovic MT, Moreland RB, Brioni JD, Stewart AO (2004) Synthesis and functional activity of (2-aryl-1-piperazinyl)-N- (3-methylphenyl)acetamides: selective dopamine D4 receptor agonists. Bioorg Med Chem 12:3471-3483
153. McCombe JA, Auer RN, Maingat FG, Houston S, Gill MJ, Power C (2009) Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology 72(9):835-841. doi: 10.1212/01.wnl.0000343854.80344.69
154. McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG (2006) Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci Off J Soc Neurosci 26(37):9365-9375. doi: 10.1523/JNEUROSCI.1504-06.2006
155. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ (2002) Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132(1-2):34-40
156. McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A, Berman JW (2000) Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 156(4):1441-1453. doi: 10.1016/S0002-9440(10)65013-4
157. Meade CS, Conn NA, Skalski LM, Safren SA (2011a) Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. J Behav Med 34(2):128-138. doi: 10.1007/s10865-010-9293-5
158. Meade CS, Lowen SB, MacLean RR, Key MD, Lukas SE (2011b) fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence. Psychiatry Res 192(3):167-175. doi: 10.1016/j.pscychresns.2010.12.011
159. Meintjes G, Boulle A (2012) Immune reconstitution inflammatory syndrome in a large multicenter cohort study: case definition and comparability. Expert Rev Anti-Infect Ther 10(7):737-741. doi: 10.1586/eri.12.62
160. Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, Santamaria EK, Bell J (2009) Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care 21(2):168-177. doi: 10.1080/09540120802001705
161. Merrill JE, Koyanagi Y, Chen IS (1989) Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 63(10):4404-4408
162. Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, Huff RM (1995) Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. Eur J Pharmacol 290:29-36
163. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78(1):189-225
164. Mocchetti I, Bachis A, Avdoshina V (2012) Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. Neurotox Res 21(1):79-89. doi: 10.1007/s12640-011-9279-2
165. Molinoff PB, Axelrod J (1971) Biochemistry of catecholamines. Annu Rev Biochem 40:465-500. doi: 10.1146/annurev.bi.40.070171.002341
166. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7):2348-2357
167. Muller WA (2011) Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 6:323-344. doi: 10.1146/annurev-pathol-011110-130224
168. Nahvi S, Litwin AH, Heo M, Berg KM, Li X, Arnsten JH (2012) Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. Drug Alcohol Depend 120(1-3):174-180. doi: 10.1016/j.drugalcdep. 2011.07.025
169. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S (2008) Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 373(2):286-291. doi: 10.1016/j.bbrc.2008.06.012
170. Nakano K, Higashi T, Takagi R, Hashimoto K, Tanaka Y, Matsushita S (2009) Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 21(6):645-654. doi: 10.1093/intimm/dxp033
171. Napolitano A, Cesura AM, Da Prada M (1995) The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm Suppl 45:35-45
172. Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14(3):222-227
173. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(Suppl 2):S62-S69
174. Nathan CF (1983) Mechanisms of macrophage antimicrobial activity. Trans R Soc Trop Med Hyg 77(5):620-630
175. Nelson CA, Zunt JR (2011) Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis Off Publ Infect Dis Soc Am 53(9):915-926. doi: 10.1093/cid/cir508
176. Nguyen TP, Soukup VM, Gelman BB (2010) Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol 176(2):893-902. doi: 10.2353/ajpath.2010.090390
177. Nockher WA, Bergmann L, Scherberich JE (1994) Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol 98(3):369-374
178. Nuovo GJ, Alfieri ML (1996) AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 2(3):358-366
179. Pacelli R, Wink DA, Cook JA, Krishna MC, DeGraff W, Friedman N, Tsokos M, Samuni A, Mitchell JB (1995) Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med 182(5):1469-1479
180. Parsons LH, Justice JB Jr (1992) Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J Neurochem 58(1):212-218
181. Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB (1996) Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor. Mol Pharmacol 50:1658-1664
182. Peluso R, Haase A, Stowring L, Edwards M, Ventura P (1985) A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 147(1):231-236
183. Persidsky Y, Zheng J, Miller D, Gendelman HE (2000) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68(3):413-422
184. Peterson RA (2012) Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 40(2):186-204. doi: 10.1177/0192623311430693
185. Petito CK, Adkins B, McCarthy M, Roberts B, Khamis I (2003) CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J Neurovirol 9(1):36-44. doi: 10.1080/13550280390173391
186. Pierce RC, Kumaresan V (2006) The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30(2):215-238. doi: 10.1016/j.neubiorev.2005.04.016
187. Post MJ, Thurnher MM, Clifford DB, Nath A, Gonzalez RG, Gupta RK, Post KK (2012a) CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome. AJNR Am J Neuroradiol. doi: 10.3174/ajnr.A3183
188. Post MJ, Thurnher MM, Clifford DB, Nath A, Gonzalez RG, Gupta RK, Post KK (2012b) CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens. AJNR Am J Neuroradiol. doi: 10.3174/ajnr.A3184
189. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349(9053):692-695. doi: 10.1016/S0140-6736(96)10178-1
190. Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Mol Neurobiol 44(1):102-110. doi: 10.1007/s12035-011-8195-z
191. Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V (2006) Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J 25(1):53-58
192. Qandil AM, Lewis MM, Jassen A, Leonard SK, Mailman RB, Nichols DE (2003) Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de] isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands. Bioorg Med Chem 11:1451-1464
193. Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65(4):458-465
194. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 104(2):654-659. doi: 10.1073/pnas.0604049104
195. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc JINS 10(1):1-14. doi: 10.1017/S1355617704101021
196. Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS (2004) Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol 157(1-2):81-92. doi: 10.1016/j.jneuroim.2004.08.030
197. Roberts TK, Eugenin EA, Lopez L, Romero IA, Weksler BB, Couraud PO, Berman JW (2012) CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab Investig J Tech Methods Pathol 92(8):1213-1233. doi: 10.1038/labinvest.2012.80
198. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21(14):1915-1921. doi: 10.1097/QAD.0b013e32828e4e27
199. Rohr O, Sawaya BE, Lecestre D, Aunis D, Schaeffer E (1999a) Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system. Nucleic Acids Res 27(16):3291-3299
200. Rohr O, Schwartz C, Aunis D, Schaeffer E (1999b) CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine. J Cell Biochem 75(3):404-413
201. Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, Borrelli E (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci Off J Soc Neurosci 22(8):3293-3301
202. Roy B, Rai U (2004) Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis. Gen Comp Endocrinol 136(2):180-191. doi: 10.1016/j.ygcen.2003.12.023
203. Rudd ML, Nicolas AN, Brown BL, Fischer-Stenger K, Stewart JK (2005) Peritoneal macrophages express the serotonin transporter. J Neuroimmunol 159(1-2):113-118. doi: 10.1016/j.jneuroim.2004.10.013
204. Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115-121. doi: 10.1080/13550280290101094
205. Saha B, Mondal AC, Basu S, Dasgupta PS (2001) Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis. Int Immunopharmacol 1(7):1363-1374
206. Santambrogio L, Lipartiti M, Bruni A, Dal Toso R (1993) Dopamine receptors on human T- and B-lymphocytes. J Neuroimmunol 45(1-2):113-119
207. Sarkar C, Das S, Chakroborty D, Chowdhury UR, Basu B, Dasgupta PS, Basu S (2006) Cutting edge: stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation. J Immunol 177(11):7525-7529
208. Sautel F, Griffon N, Levesque D, Pilon C, Schwartz JC, Sokoloff P (1995) A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport 6:329-332
209. Scheller C, Sopper S, Jassoy C, ter Meulen V, Riederer P, Koutsilieri E (2000) Dopamine activates HIV in chronically infected T lymphoblasts. J Neural Transm 107(12):1483-1489
210. Schiffer WK, Azmoodeh M, Gerasimov M, Volkow ND, Fowler JS, Dewey SL (2003) Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine. Synapse 48(1):35-38. doi: 10.1002/syn.10183
211. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283(5403):857-860
212. Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozzani S, Girolomoni G, Cavani A (2001) Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166(2):996-1002
213. Seeman P, Van Tol HH (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270
214. Seeman P, Tallerico T, Ko F (2003) Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: implications for human positron emission tomography. Synapse 49:209-215
215. Shankar EM, Vignesh R, Velu V, Murugavel KG, Sekar R, Balakrishnan P, Lloyd CA, Saravanan S, Solomon S, Kumarasamy N (2008) Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease? J Inflamm (Lond) 5:2. doi: 10.1186/1476-9255-5-2
216. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ (2005) Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19(4):399-406
217. Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, Aguon J, Valcour V (2005) Circulating proviral HIV DNA and HIV-associated dementia. AIDS 19(1):45-52
218. Shurtleff D, Lawrence D (2012) HIV and substance abuse: a commentary. Curr HIV Res
219. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24(9):1243-1250. doi: 10.1097/QAD.0b013e3283354a7b
220. Sohler NL, Wong MD, Cunningham WE, Cabral H, Drainoni ML, Cunningham CO (2007) Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STDs 21(Suppl 1):S68-S76. doi: 10.1089/apc.2007.9985
221. Sokoloff P, Andrieux M, Besancon R, Pilon C, Martres MP, Giros B, Schwartz JC (1992) Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol 225:331-337
222. Sozzani S, Ghezzi S, Iannolo G, Luini W, Borsatti A, Polentarutti N, Sica A, Locati M, Mackay C, Wells TN, Biswas P, Vicenzi E, Poli G, Mantovani A (1998) Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187(3):439-444
223. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76(2):301-314
224. Starace F, Baldassarre C, Biancolilli V, Fea M, Serpelloni G, Bartoli L, Maj M (1998) Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study. Acta Psychiatr Scand 97(2):132-138
225. Steinman RM (2007) Lasker basic medical research award. Dendritic cells: versatile controllers of the immune system. Nat Med 13(10):1155-1159. doi: 10.1038/nm1643
226. Sternberg EM, Wedner HJ, Leung MK, Parker CW (1987) Effect of serotonin (5-HT) and other monoamines on murine macrophages: modulation of interferon-gamma induced phagocytosis. J Immunol 138(12):4360-4365
227. Stewart AO, Cowart MD, Moreland RB, Latshaw SP, Matulenko MA, Bhatia PA, Wang X, Daanen JF, Nelson SL, Terranova MA, Namovic MT, Donnelly-Roberts DL, Miller LN, Nakane M, Sullivan JP, Brioni JD (2004) Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H- benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. J Med Chem 47:2348-2355
228. Strell C, Sievers A, Bastian P, Lang K, Niggemann B, Zanker KS, Entschladen F (2009) Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes. BMC Immunol 10:62. doi: 10.1186/1471-2172-10-62
229. Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72(17):1458-1464. doi: 10.1212/01.wnl.0000343510.08643.74
230. Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC (2012) HIV-associated opportunistic infections of the CNS. Lancet Neurol 11(7):605-617. doi: 10.1016/S1474-4422(12)70098-4
231. Tarazona R, Gonzalez-Garcia A, Zamzami N, Marchetti P, Frechin N, Gonzalo JA, Ruiz-Gayo M, van Rooijen N, Martinez C, Kroemer G (1995) Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J Immunol 154(2):861-870
232. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25(12):3418-3424. doi: 10.1002/eji.1830251232
233. Tomlinson GS, Simmonds P, Busuttil A, Chiswick A, Bell JE (1999) Upregulation of microglia in drug users with and without pre-symptomatic HIV infection. Neuropathol Appl Neurobiol 25(5):369-379
234. Torres KC, Antonelli LR, Souza AL, Teixeira MM, Dutra WO, Gollob KJ (2005) Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol 166(1-2):144-157. doi: 10.1016/j.jneuroim.2005.06.006
235. Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retrovir 21(8):706-713. doi: 10.1089/aid.2005.21.706
236. Tsambiras PE, Larkin JA, Houston SH (2001) Case report. Toxoplasma encephalitis after initiation of HAART. AIDS Read 11(12):608-610, 615-606
237. Tsao CW, Lin YS, Cheng JT (1998) Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci 62(21):PL 335-PL 344
238. Turner BJ, Fleishman JA, Wenger N, London AS, Burnam MA, Shapiro MF, Bing EG, Stein MD, Longshore D, Bozzette SA (2001) Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med 16(9):625-633
239. Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM (1998) Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 72(6):4962-4969
240. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31(4):349-360. doi: 10.1002/ana.410310402
241. Valcour VG, Shiramizu BT, Shikuma CM (2010) HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol 87(4):621-626. doi: 10.1189/jlb.0809571
242. Valcour V, Sithinamsuwan P, Letendre S, Ances B (2011) Pathogenesis of HIV in the central nervous system. Curr HIV AIDS Rep 8(1):54-61. doi: 10.1007/s11904-010-0070-4
243. Venton BJ, Zhang H, Garris PA, Phillips PE, Sulzer D, Wightman RM (2003) Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem 87(5):1284-1295
244. Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523-532. doi: 10.1038/nri2343
245. von Herrath M, Oldstone MB, Fox HS (1995) Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 154(10):5582-5589
246. Wang J, Crawford K, Yuan M, Wang H, Gorry PR, Gabuzda D (2002) Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines. J Infect Dis 185(7):885-897. doi: 10.1086/339522
247. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127(Pt 11):2452-2458. doi: 10.1093/brain/awh269
248. Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, Hashimoto K, Yoshie O (2006) Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol 176(2):848-856
249. Weihe E, Eiden LE (2000) Chemical neuroanatomy of the vesicular amine transporters. FASEB J Off Publ Fed Am Soc Exp Biol 14(15):2435-2449. doi: 10.1096/fj.00-0202rev
250. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83(18):7089-7093
251. Williams MA, Bevan MJ (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25:171-192. doi: 10.1146/annurev.immunol.25.022106.141548
252. Williams KC, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537-562. doi: 10.1146/annurev.neuro.25.112701.142822
253. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193(8):905-915
254. Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, Kim WK, Fuller RA, Kim JP, Autissier P, Sehgal PK, Schinazi RF, Bischofberger N, Piatak M, Lifson JD, Masliah E, Gonzalez RG (2005) Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Investig 115(9):2534-2545. doi: 10.1172/JCI22953
255. Williams DW, Eugenin EA, Calderon TM, Berman JW (2012) Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 91(3):401-415. doi: 10.1189/jlb.0811394
256. Witwer KW, Gama L, Li M, Bartizal CM, Queen SE, Varrone JJ, Brice AK, Graham DR, Tarwater PM, Mankowski JL, Zink MC, Clements JE (2009) Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One 4(12):e8129. doi: 10.1371/journal.pone.0008129
257. Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS (2003) Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 169(7):656-661
258. Woods ML 2nd, MacGinley R, Eisen DP, Allworth AM (1998) HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12(12):1491-1494
259. Xi ZX, Kleitz HK, Deng X, Ladenheim B, Peng XQ, Li X, Gardner EL, Stein EA, Cadet JL (2009) A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats. Neuroscience 161(2):392-402. doi: 10.1016/j.neuroscience.2009.03.060
260. Xing HQ, Hayakawa H, Izumo K, Kubota R, Gelpi E, Budka H, Izumo S (2009) In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathol Off J Jpn Soc Neuropathol 29(4):433-442. doi: 10.1111/j.1440-1789.2008.00996.x
261. Yadav A, Collman RG (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J NeuroImmune Pharm Off J Soc NeuroImmune Pharm 4(4):430-447. doi: 10.1007/s11481-009-9174-2
262. Zachek MK, Takmakov P, Park J, Wightman RM, McCarty GS (2010) Simultaneous monitoring of dopamine concentration at spatially different brain locations in vivo. Biosens Bioelectron 25(5):1179-1185. doi: 10.1016/j.bios.2009.10.008
263. Zheng J, Thylin MR, Persidsky Y, Williams CE, Cotter RL, Zink W, Ryan L, Ghorpade A, Lewis K, Gendelman HE (2001) HIV-1 infected immune competent mononuclear phagocytes influence the pathways to neuronal demise. Neurotox Res 3(5):461-484
264. Zhu J, Paul WE (2008) CD4 T cells: fates, functions, and faults. Blood 112(5):1557-1569. doi: 10.1182/blood-2008-05-078154
265. Ziegler-Heitbrock HW, Fingerle G, Strobel M, Schraut W, Stelter F, Schutt C, Passlick B, Pforte A (1993) The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23(9):2053-2058. doi: 10.1002/eji.1830230902